OraSure Technologies, Inc.

    Jurisdiction
    United States
    LEI
    529900GNNJPNM4XHXQ77
    ISIN
    US68554V1089 (OSUR)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    InsiderPie Expert Score
    trending_up 52 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €33.11M
    Gross margin
    108.2%
    EBIT
    -€31.42M
    EBIT margin
    -94.9%
    Net income
    -€43.69M
    Net margin
    -132.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €108.35M +227.2% -€45.00M +3.0%
    €116.86M +7.9% -€39.93M -11.3%
    N/A N/A

    Dividends

    Last dividend amount
    $1.60
    Ex date

    Earnings Calls

    Latest earnings call: May 8, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 2.6M $8.66M -203K Sell

    Add to watchlist

    Notifications